Objectives:

  1. To provide a brief history on the treatment of head and neck squamous cell carcinoma
  2. To discuss methods to improve induction therapy response rate in head and neck cancer
  3. To describe the role of combination immunotherapy and radiation in non-small cell lung cancer

 

Session date: 
Monday, August 27, 2018 - 12:00pm to 1:00pm
Speaker Name: 
Michael J. Jelinek, MD
Location: 
UCMC
5841 South Maryland Avenue
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.